Effects of Ultrasound Therapy in Iliotibial Band Syndrome
Effects of Ultrasound Therapy in Patients With Iliotibial Band Syndrome
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Şişli
-
Istanbul, Şişli, Turkey (Türkiye), 34384
- Prof.Dr.Cemil Taşcıoğlu Şehir Hastanesi
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria: - Aged between 45 and 60 years -Patients diagnosed with ITBS using ITB trigger point palpation and the Noble compression test -Visual Analogue Scale (VAS) score ≥50 mm
Exclusion Criteria:
- History of lower limb surgery within the last six month- Body weight exceeding 120 kg- History of malignancy-Severe coxarthrosis-Severe osteoporosis-Stage 4 gonarthrosis-Lower limb surgey in the last 6 months-History of any neurological, vascular or infectious disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Exercise
|
Hip and knee strengthening, core muscle strengthening, and ITB stretching exercises were given in 15 sessions.
|
|
Experimental: Exercise and continious ultrasound
|
Hip and knee strengthening, core muscle strengthening, and ITB stretching exercises were given in 15 sessions.
2 W/cm² intensity, 1.5 MHz frequency, 7 minutes, 15 continuous ultrasound sessions.
|
|
Experimental: Exercise and intermittant ultrasound
|
Hip and knee strengthening, core muscle strengthening, and ITB stretching exercises were given in 15 sessions.
2 W/cm² intensity, 1.5 MHz frequency, 7 minutes per session, 15 pulsed ultrasound treatments.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
VAS and LEFS
Time Frame: Before treatment, at the end of treatment (after 15 sessions) , and 3 months after treatment.
|
Pain intensity was assessed using the VAS.
Patients were asked to mark their pain levels on a straight line ranging from 0 to 10 cm; 0 denoted no pain, whilst 10 denoted severe pain.Lower limb functional status was assessed using the LEFS scale.
The scale, consisting of a total of 20 items, was scored according to five numerical response categories ranging from 0 (extreme difficulty/unable to perform the activity) to 4 (no difficulty).
The total score was assessed on a scale of 0 to 80. Higher scores were associated with better functional status
|
Before treatment, at the end of treatment (after 15 sessions) , and 3 months after treatment.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
SF-12 and ITB thickness
Time Frame: Before treatment, at the end of treatment (after 15 sessions) , and 3 months after treatment.
|
General physical and mental health status was assessed using the Short Form-12 (SF-12), a 12-item version of the SF-36.
Higher scores were associated with a better quality of life.
The thickness of the ITB was assessed using an USG scanner.
|
Before treatment, at the end of treatment (after 15 sessions) , and 3 months after treatment.
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- İTBS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.